PROTHENA CORPORATION PUBLIC LIMITED COMPANY Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2025-02-27: Form 10-K; Item Well-known seasoned issuer; As filed Yes.
- 2024-02-22: Form 10-K; Item Well-known seasoned issuer; As filed Yes.
- 2023-02-28: Form 10-K; Item Well-known seasoned issuer; As filed Yes.
- 2022-02-25: Form 10-K; Item Well-known seasoned issuer; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2025-02-27 | 10-K | Well-known seasoned issuer | Yes |
| 2024-02-22 | 10-K | Well-known seasoned issuer | Yes |
| 2023-02-28 | 10-K | Well-known seasoned issuer | Yes |
| 2022-02-25 | 10-K | Well-known seasoned issuer | Yes |
| 2021-11-04 | 10-Q | Smaller reporting company | Yes |
| 2021-08-05 | 10-Q | Smaller reporting company | Yes |
| 2021-05-11 | 10-Q | Smaller reporting company | Yes |
| 2021-02-26 | 10-K | Smaller reporting company | Yes |
| 2020-11-04 | 10-Q | Smaller reporting company | Yes |
| 2020-08-06 | 10-Q | Smaller reporting company | Yes |
| 2020-05-06 | 10-Q | Smaller reporting company | Yes |
| 2020-03-03 | 10-K | Smaller reporting company | Yes |
| 2019-11-05 | 10-Q | Smaller reporting company | Yes |
| 2019-08-06 | 10-Q | Smaller reporting company | Yes |
| 2019-05-07 | 10-Q | Smaller reporting company | Yes |
| 2019-03-15 | 10-K | Smaller reporting company | Yes |
| 2018-02-26 | 10-K | Well-known seasoned issuer | Yes |
| 2017-02-27 | 10-K | Well-known seasoned issuer | Yes |
| 2016-02-25 | 10-K | Well-known seasoned issuer | Yes |
| 2015-03-13 | 10-K | Well-known seasoned issuer | Yes |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |